Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Descemet's membrane is the specialized basement membrane of the corneal endothelium, situated between the corneal stroma and the endothelial layer [1]. It is primarily composed of a hexagonal lattice of collagen type VIII and a basement membrane-like meshwork of collagen type IV, laminin, and fibronectin [2]. Biologically, it serves as a structural scaffold for the attachment and migration of corneal endothelial cells, which are vital for maintaining corneal dehydration and transparency [1, 3]. Pathologically, the membrane is central to conditions like Fuchs' endothelial corneal dystrophy, where it thickens and develops collagenous excrescences known as guttae, and keratoconus, where it may rupture [3, 4]. While it is a critical site for surgical interventions like Descemet Membrane Endothelial Keratoplasty (DMEK), it does not function as a molecular receptor or enzyme for drug binding, making it an anatomical structure rather than a traditional therapeutic target [5]. Sources: [1] StatPearls, 'Anatomy, Eye, Cornea' (https://www.ncbi.nlm.nih.gov/books/NBK544216/) [2] Wikipedia, 'Descemet's membrane' (https://en.wikipedia.org/wiki/Descemet%27s_membrane) [3] NIH/NEI, 'Fuchs' Dystrophy' (https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/fuchs-dystrophy) [4] PubMed, 'The role of Descemet's membrane in corneal disease' (https://pubmed.ncbi.nlm.nih.gov/11063244/) [5] American Academy of Ophthalmology, 'Descemet Membrane Endothelial Keratoplasty' (https://www.aao.org/eye-health/treatments/dmek-surgery)
Not applicable as this is an anatomical structure rather than a molecular drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Descemet's membrane (DM).